Corvus Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -1.5 | -100% |
| P/S |
|
0 | 33.75 | -100% |
|
|
| P/BV |
|
2.11 | 4.82 | -56.19% |
|
|
| P/FCF |
|
-4.7 | 61 | -107.71% |
|
|
| Ev/Ebitda |
|
-3.03 | -22.17 | -86.35% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-2.94 | 68.75 | -104.27% |
|
|
| E/P |
|
-0.2398 | 0.0178 | -1449.19% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
-69.87 | 9.61 | -826.95% |
|
|
| ROA |
|
-59.34 | 0.3443 | -17335.63% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-60.51 | 15.35 | -494.18% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0591 | -3.68 | -98.39% | -0.0634 | -6.87% |
| Nеt Debt/Ebitda |
|
0.4836 | -3.44 | -114.07% |
|
|
| Debt/Ratio |
|
0.0302 | 0.1985 | -84.8% |
|
|
| Debt/Equity |
|
0.0325 | 1.66 | -98.05% |
|
|
| Debt/Net Income |
|
-0.0508 | 10.32 | -100.49% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-44.98 | -54.68 | -17.74% | ||
| Growth impulse Net Income in 5 years |
|
-38.22 | -58.33 | -34.48% | ||
| Growth impulse FCF in 5 years |
|
-35.82 | -49.48 | -27.61% | ||
| Growth impulse EPS in 5 years |
|
-62.24 | -32.41 | 92.04% |
IP Score
2.68/10
